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Abstract
Given the important role of treatment attendance as an indicator of program implementation and
as a potential moderator of program effectiveness, this study sought to develop useful indicators of
attendance for evidence-based practices. The current study examined consumer attendance
patterns in a randomized controlled trial comparing illness management and recovery (n = 60) to a
problem solving control condition (n = 58). Associations were examined between consumer
clinical indicators, demographics, and level of recovery and indices of attendance. Attendance was
poor, but comparable to rates found in many other studies. Four indicators of attendance (percent
sessions attended, time enrolled, periods of attendance, and longest period of attendance) were
highly inter-related and were more sensitive to baseline differences than a traditional approach of
dichotomizing participants into “attenders” and “non-attenders.” Older age, lower hostility, fewer
psychotic symptoms, and more education were associated with higher group attendance in both
treatment conditions; the client-reported illness management and recovery scale was associated
with attendance in the control group. Indicators of attendance were an advancement over
dichotomous classification. Strategies to increase attendance are still needed, particularly for
younger consumers with greater positive symptoms.
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1. Introduction
Research and practice emphasize implementation of evidence-based practices (EBPs) in
mental health care for consumers with severe mental illness (SMI); consumer attendance is a
key indicator of feasibility of a practice (Proctor et al., 2011), or the extent to which a
practice can be successfully carried out within a given setting (Karsh, 2004). If a program
can be established, but consumers do not attend services or drop-out early, the program is of
little use to consumers. To this end, consumers who terminate services early demonstrate
worse outcomes than treatment completers (Pekarik, 1983, 1985a; Masi et al., 2003).
Additionally, missed sessions drain system resources and may exact an emotional toll on
treatment providers (Salmoiraghi and Sambhi, 2010).
Substantial research has explored predictors of attendance, including four systematic
reviews (Chen, 1991; Wierzbicki and Pekarik, 1993; Nose et al., 2003; O'Brien et al., 2009),
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which have produced confusing and inconsistent results. There is some consensus, with
most authors agreeing that greater dropout is associated with younger age, minority race,
and substance abuse. But individual reviews have concluded factors such as insight (O'Brien
et al., 2009), social functioning (Nose et al., 2003), and education and income (Wierzbicki
and Pekarik, 1993) are “consistently” associated with attendance, without confirmation from
other reviews. At the same time, many theoretically relevant constructs are currently
neglected in the empirical literature (e.g., stigma (Corrigan and Rüsch, 2002), although see
Fung et al. (2008) for an excellent counterexample).
The confusing and inconclusive literature has led many scholars (Baekeland and Lundwall,
1975; Wierzbicki and Pekarik, 1993; Nose et al., 2003; O'Brien et al., 2009) to conclude that
methodological issues are a major issue. In particular, “definitional inexplicitness has been
the hallmark of most studies of dropping out of treatment” (Baekeland and Lundwall, 1975,
p. 740). For instance, participants are often dichotomized arbitrarily (Sue et al., 1976; Beard
et al., 1978; Cohen et al., 1995; King and Canada, 2004; Latimer et al., 2006; Harding et al.,
2008). In coding participants to one of only two attendance groups, untold variance in
attendance patterns is lost, thus limiting both statistical power and the clinical utility of the
results. Further, there may be different aspects of attendance that are important. One study
found that variables correlated with attendance could manifest differing relationships when
the attendance outcome was operationalized differently (Pekarik, 1985b).
Another potential explanation for the variation in predictors of attendance is the
heterogeneity of mental health services studied. A dearth of literature has focused on
predictors of attendance in EBPs for people with SMI. To demonstrate in three sample
EBPs, only four studies have examined predictors of attendance in participants with SMI:
illness management and recovery (two studies) (Bullock et al., 2007; Salyers et al., 2011),
cognitive-behavioral therapy for psychosis (one study; Tarrier et al., 1998), and supported
employment (one study; Harding et al., 2008). Results from these studies are not conclusive
regarding predictors of attendance. In a recent study examining hospital and emergency
room use in illness management and recovery participants, fewer hospitalizations, older age,
absence of substance abuse, more education, white race, and being single were associated
with lower drop-out rates (Salyers et al., 2011). However, Bullock et al. (2007) found no
significant predictors of illness management and recovery attendance, (although this may
have been due to lack of statistical power). Tarrier et al. (1998) found dropouts from
cognitive-behavioral therapy for psychosis had lower premorbid IQ and a trend toward
higher baseline depression. In a study comparing two vocational programs, drop-outs
(within 6-months) were likely to be more educated, never married, have a schizophrenia-
spectrum diagnosis, and be assigned to the stepwise program (as opposed to the supported
employment condition) (Harding et al., 2008). Some studies of other, non-SMI populations
have found equally inconclusive results (c.f., Eskildsen et al., 2010).
We sought to further the literature by describing attendance within the context of a
randomized-controlled trial of an EBP – illness management and recovery (Mueser et al.,
2002; Hasson-Ohayon et al., 2007; Levitt et al., 2009; Färdig et al., 2011) using more
nuanced indicators of attendance. Illness management and recovery is a 10-month
curriculum designed to help consumers with SMI develop goals and be more active and
informed about their mental health treatment. We contend that illness management and
recovery provides a reasonable example of a clinically complex, recovery-oriented EBP and
therefore results may be generalizable to other important practices. We sought to explore the
utility of various indicators of attendance by examining sensitivity to differences in
consumer characteristics. These indicators are compared to the conventional standard of
dichotomization by “attenders” versus “non-attenders.” Moreover, the inclusion of a control
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condition allowed us to compare differential attendance and predictors between participants
assigned to a recovery-oriented EBP and a non-specific service.
2. Methods
2.1. Sample
Participants were enrolled in a randomized-controlled trial comparing illness management
and recovery to an active control condition (unstructured problem solving groups).
Participants were recruited from a VA medical center and a community mental health center
(CMHC) serving consumers with SMI in an urban area. Inclusion criteria were: receiving
services at either location, age ≥ 18, diagnosed with schizophrenia or schizoaffective
disorder confirmed by the psychotic modules of the Structured Clinical Interview for DSM-
IV (First et al., 1996), no severe cognitive dysfunction according to a cognitive screen
(Callahan et al., 2002), and no physical health condition that would limit participation in an
18-month study. Participants were randomized into treatment condition (illness management
and recovery vs. problem solving control). Participants from both groups are included in
these analyses.
Baseline characteristics for the sample are shown in Tables 1 and 2. Participants in the
illness management and recovery condition (n = 60) did not differ from the controls (n = 58)
on any baseline characteristics. Participants receiving services at the CMHC (M = 18.3, S.D.
= 3.68) had more hope at baseline than VA participants (M = 16.6, S.D. = 4.09, t = –2.30,
d.f. = 114, p = 0.02) but did not differ on any other measure. Power Analyses: our sample of
n = 118 allows us to detect medium effects (effect size ≈ 0.35) at alpha = 0.05, Power =
0.80 (Lipsey, 1990).
2.2. Measures
2.2.1. Attendance—Participants signed in at each session; participants’ attendance was
confirmed via medical records and session audio-recordings when needed. Attendance was
measured in several ways. Percent sessions attended: because the number of sessions
available varied for each consumer's study phase (due to length of months and holiday
cancellations), we used the number of sessions attended divided by the number of sessions
occurring during their active treatment phase. This indicator is roughly analogous to “dose”
of the intervention received. Time enrolled (reported as a percent of total available sessions)
is the time from the participant's first eligible session until the last session the participant
attended, regardless of whether a participant missed sessions between the first and last. For
instance, the last session Consumer 2 (Fig. 1) attended was session seven; therefore, this
consumer's time enrolled would be 7/13 sessions = 54%. Periods of attendance were
operationally defined as starting when a participant attended at least two sessions (the
minimum number that can indicate a pattern of attendance) in a four-session period and
ending when the participant missed at least four consecutive sessions. These cut-points
roughly correspond to the length of one module in illness management and recovery. In Fig.
1, Consumers 1 and 2 both had one distinct period of attendance, while Consumer 3 had
two. We also calculated the longest period of attendance, which was considered meaningful
because continuous exposure could be more potent than exposure to an equal number of
sessions spread over a large period of time. Finally, for a typical indicator of attendance, we
calculated whether participants attended at least 50% of sessions (Corrigan, 1995; Okpaku et
al., 1997).
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2.2.2. Demographics included age, race, gender, marital status, educational
level, and housing status
2.2.2.1. Clinical consumer characteristics: Symptoms were measured using the positive
and negative syndrome scale (PANSS; Kay et al., 1987; a semi-structured interview with
previously demonstrated satisfactory alpha levels (between 0.73 and 0.83) and good
reliability and validity (Peralta and Cuesta, 1994). We used the five-factor (positive,
negative, cognitive, hostility, and emotional) scoring model (Bell et al., 1994).
The illness management and recovery scales (IMRS) were developed as outcome measures
for illness management and recovery (Mueser and Gingerich, 2005). There are parallel client
and clinician versions, each containing 15 items. The possible score on each item ranges
from 1 to 5, with higher scores indicating better outcomes. The IMRS have shown adequate
internal consistency (Cronbach's alpha > = 0.71), strong test-retest correlations over a two-
week period (both versions, r = 0.81, p < 0.001), and correlations with other indices of
functioning, symptoms, and recovery (Salyers et al., 2007; Hasson-Ohayon et al., 2008;
Fardig et al., 2011).
The alcohol use scale-revised (AUR) and drug use scale-revised (DUS-R; Drake et al.,
1990) are 5-point rating scales assessing use within the past 6 months. Both instruments
have been shown to have high inter-rater reliability (kappa coefficient between 0.80 and
0.95) and the AUS-R has demonstrated high sensitivity (95%) and specificity (100%; Drake
et al., 1996b).
The medication adherence rating scale (MARS) is a 10-item scale scored from 0 to 10, with
lower scores indicating better adherence. The MARS has been shown to have adequate
internal consistency (Cronbach's alpha = 0.75), test-retest reliability (ICC = 0.72), and
construct validity, correlating with the Medication Adherence Questionnaire (r = 0.79) and
the Drug Attitude Inventory (r = 0.82; Thompson et al., 2000).
The Patient Activation Measure (Hibbard et al., 2010) assesses patient's knowledge, skill,
and confidence health self-management. We used the 13-item mental health version (PAM-
MH; Green et al., 2010), which focuses on the management of mental illness. The PAM-MH
has a 0–100 theoretical scale with higher scores indicating better patient activation. The
measure has been found to have comparable reliability (person-item reliability = 0.84 and
item-reliability = 0.97) and construct validity as the original (Hibbard et al., 2004).
The recovery assessment scale (RAS; Corrigan et al., 1999) is a 41-item scale designed to
assess perceptions of recovery for people with SMI. RAS total has shown good test-retest
reliability, internal consistency (alpha = 0.93), and correlations with measures of self-
esteem, empowerment, and quality of life.
2.2.2.2. Treatment model integrity: Was confirmed using the illness management and
recovery treatment integrity scale (IT-IS; McGuire et al., 2012). IT-IS ratings are made
based on audio-recordings of a session. It a 16-item scale which has demonstrated good
internal consistency (alpha = 0.90), inter-rater reliability, and the ability to distinguish
between illness management and recovery and control sessions.
2.3. Procedures
Participants were randomized to illness management and recovery or problem solving and
asked to attend their assigned group for a 9-month active treatment phase (which was
followed by a 9-month non-active phase in which they did not receive study interventions).
Baseline interviews were conducted by trained research staff. Treatment groups were
facilitated by mental health professionals, including a master's-level social worker and
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doctoral-level psychologists (authors #1 & #3) who had previous experience providing
illness management and recovery. Groups were co-facilitated by clinical psychology
graduate students with a range of clinical experience.
Problem solving groups were unstructured process groups. Participants were encouraged to
use the time to discuss problems and lend mutual support. Group leaders were prohibited
from using illness management and recovery materials or techniques. The same group
leaders facilitated the experimental and control conditions.
2.4. Analyses
We first calculated descriptive statistics for each indicator of attendance. We compared
illness management and recovery and problem solving groups on each indicator of
attendance using independent samples t-tests. We examined interrelationships between
indicators of attendance by first calculating Pearson's correlations. We explored the
relationship between baseline consumer characteristics (demographics, baseline symptoms,
and recovery-related variables) and indicators of attendance using Person's r (for continuous
variables) and point-biserial correlations for dichotomous variables. Zero-order correlations
were used because of the exploratory nature of identifying which characteristics may be
related to each indicator of attendance.
3. Results
3.1. Group attendance patterns
The number of possible sessions (for all participants) available for attendance ranged from
38 to 42. On average, participants attended less than a quarter of available sessions and
stopped prior to half of potential sessions that had been offered; see Table 1 for descriptive
statistics of indicators of attendance. Twenty-seven (22.9%) participants attended at least
50% of sessions. In terms of discrete periods of attendance, most participants (56; 47.5%)
had no periods of attendance (i.e., did not attend ≥ 2 sessions), followed by one period of
attendance (n = 45, 38.1%), two periods (n = 12, 10.2%), and three periods (n= 5, 4.2%).
Participants’ longest period of attendance averaged about nine sessions; considering only
participants with at least one period of attendance (n = 62), participants’ longest period of
attendance was about eighteen sessions (M = 17.8; median = 16.5; S.D. = 12.04). Taken
together, the average participant did not have any periods of active attendance. For
participants who did have active periods of attendance, it was generally just one period that
lasted about eighteen sessions.
Participants in illness management and recovery attended more sessions (M = 47.0%, S.D. =
41.60) than controls (M = 31.9%, S.D. = 41.60; t(116) = –2.0, p = 0.05), but did not differ on
any other measure of attendance. Examining session-by-session attendance patterns (Fig. 2),
both conditions experienced sharp declines in the number of participants during the first
month of treatment, followed by slow decline for the duration of the study period.
3.2. Inter-relation of indicators of attendance
Indicators of attendance were strongly correlated (Table 1). However, the correlation
amongst percentage of sessions attended, time enrolled, and longest period of attendance (r
ranges from 0.83 to 0.94) were stronger than the correlations between the number of periods
of attendance and the other indicators (r ranges from 0.52 to 0.75).
Finally, we explored the relationship between a conventional indicator of attendance – at
least 50% sessions attended – with our indicators of attendance. The dichotomization was
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strongly correlated with the three inter-correlated indicators of attendance above (r = 0.70–
0.87) and moderately correlated with the number of periods of attendance (r = 0.42).
3.3. Prediction of attendance
Associations between participant characteristics at baseline and attendance indicators are
shown in Tables 1 and 2. Three variables were consistently associated with indicators of
attendance: age, IMR Scale-Clinician version, and hostility. Higher hostility was associated
with significantly poorer attendance on all indicators. Older age and higher scores on the
IMRS-Clinician version were associated with significantly better attendance on all
indicators except longest period of attendance. In addition, less severe overall symptoms and
positive symptoms, higher educational levels, and absence of alcohol abuse were associated
with significantly better attendance on at least one of the four indicators of attendance. The
dichotomized attendance measure was significantly correlated to only one consumer
baseline characteristic – positive symptoms (r = –0.24, p < 0.01).
We also examined the association between participant characteristics and indicators of
attendance within illness management and recovery and problem solving conditions. Results
were similar for all predictors except education and both IMRSs. Although more education
was associated with significantly better attendance in the illness management and recovery
condition (as it was in the full sample), no such relationship was observed in the problem
solving condition. There was no association between baseline IMRS-Client version and
indicators of attendance in illness management and recovery (as it was in the full sample).
However, in the problem-solving condition, the IMRS-Client version was associated with
percent of sessions attended (r = 0.27, p = 0.04, n = 57) and time enrolled (r = 0.27, p =
0.04, n = 57). The IMRS-Clinician version was significantly associated with attendance in
the problem solving condition (like the full sample), but there was no association between
the IMRS-Clinician version and indicators of attendance in the illness management and
recovery condition.
4. Discussion
Attendance in illness management and recovery and the problem solving control condition
varied widely, but was poor overall. The majority of participants had little treatment
exposure – median percentage of attendance was 7% of sessions and median time enrolled
was only 18% of the active period. This is consistent with drop-out generally occurring early
in the treatment process (Bados et al., 2007). It is notable that illness management and
recovery participants attended more sessions and dropped-out later than controls.
The level of attendance in the current study is consistent with attendance found in some
other studies of EBPs for individuals with SMI (e.g., cognitive-behavioral therapy; Tarrier et
al., 1998). In the absence of outreach efforts, attendance appears to be a challenge for many
EBPs for people with SMI and merits further attention and active steps to ameliorate this
problem. Potential solutions include additional supports like assertive outreach (e.g., Carroll
et al., 2006; Smelson et al., 2010) and tailoring of services to increase consumer
acceptability. For example, wellness management and recovery, a program adapted from
illness management and recovery based on agency and consumer feedback, is 10 sessions
long (Bullock et al., 2009). Notably, we found that the average longest period of attendance
was nine sessions–this length of attendance may speak to the feasible length of interventions
for this population.
We developed several indicators of attendance representing potential gauges of a consumer's
attendance in the intervention. These indicators were highly inter-related and no one
indicator appeared to better respond to differences in baseline characteristics than other
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indicators. Number of periods of attendance correlated more weakly with the other
indicators; these lower correlations are expected as a low number of periods of attendance
could indicate either one long period of attendance in which the participant attended
frequently or one short period of attendance in which the participant attended only four
sessions. Our attendance indicators were more sensitive than the traditional categorization of
“attenders” and “non-attenders.” Although the traditional indicator of attendance of 50%
was correlated with the other indicators and may roughly measure attendance, the restriction
of variance masks potentially meaningful associations with baseline consumer
characteristics. For example, we found the dichotomized indicator only correlated with one
baseline characteristic whereas the more nuanced indicators were related to several.
Moreover, the data used to create the dichotomy (i.e., the percent of sessions attended) is a
more powerful indicator of attendance in itself.
The successful prediction of consumer attendance is valuable to service delivery systems.
Significant resources are invested in training staff in EBPs; missed appointments represent a
significant missed opportunity (Burgoyne et al., 1983; Matas et al., 1992; VA Office of
Inspector General, 2008). Moreover, consumer characteristics associated with EBP
attendance may elucidate necessary adaptations for certain populations. For example,
educational level was associated with attendance in illness management and recovery – a
curriculum-based intervention with a workbook and homework. Consumers with less formal
education may feel uncomfortable or struggle with the program. Future research could
develop adaptations to the program to make it more acceptable to participants with lower
education.
Other predictors of attendance were equally impactful in both groups, perhaps reflecting
general predictors of attendance in group therapy. Previous literature frequently has found
older consumers (Sue et al., 1976; Young et al., 2000; Coodin et al., 2004; Bados et al.,
2007; Salyers et al., 2011) and those with less severe symptoms (Young et al., 2000; Bados
et al., 2007) to be more likely to participate in treatment. Younger, more severely disabled
populations represent a general challenge to mental health delivery systems. Furthermore,
ample literature has displayed the importance of community-based services with assertive
outreach for consumers with more severe symptoms (Burns et al., 2007).
The current study had several limitations. The study was exploratory and descriptive, and no
causal inferences should be drawn from our results. Predictor variables were those available
through the larger RCT and not selected on theoretical grounds for attendance. In addition,
the strengths of identified predictors were relatively weak. Subsequent work aimed at
examining this complex relationship will require more advanced statistical and theoretical
underpinnings; as stated by O'Brien et al. (1972), the “associations [between baseline
variables and attendance] are complex and multifaceted” (p. 558). Relevant theories of
human behavior (e.g., Goal Setting Theory (Latham and Locke, 2007) or Social Cognitive
Learning Theory (Bandura, 1991)) would provide meaningful predictors of attendance (e.g.,
self-efficacy, importance, and difficulty). Moreover, there are important predictors that may
be more difficult to quantify (e.g., group member interactions). Finally, we were unable to
take into consideration factors unrelated to the consumer that might also impact attendance.
Future research should investigate non-consumer factors in addition to theoretically relevant
consumer variables.
The indicators of attendance in the current study represent our best attempt at creating
meaningful gauges of attendance. These indicators, although promising, will require further
validation in future research. Additionally, we conducted this study in the context of a
controlled research trial; therefore, consumer attendance may not be representative of that of
consumers in routine treatment. However, this limitation is attenuated by at least three
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factors. First, although not integrated with consumers’ regular services, the study
interventions took place in community clinics already providing services to the consumers
(rather than a research-specific setting). Though we may have lost opportunities to increase
attendance had the interventions been integrated, our study has enhanced generalizability to
service systems which continue to provide brokered and non-integrated services. Second,
although participants received incentives for completing study interviews, as in most
settings, participants were not incentivized for attending treatment groups. Finally, unlike
many RCTs of psychosocial interventions, this study did not require potential participants to
attend multiple informational sessions in order to participate (e.g., Drake et al., 1996a, 1999;
Bond et al., 2007; Harding et al., 2008). Such requirements artificially select for participants
who may be more committed to attending and less likely to dropout. Nonetheless, future
studies of consumer attendance in EBPs should take into account attendance of other
services in which they are enrolled.
In summary, we developed several potential indicators of attendance in evidence-based
psychosocial interventions. These indicators were more sensitive than the traditional
dichotomous measure of attendance. However, no one indicator rises above the others and
they are highly correlated. Age, education, clinician rated IMR scale, and symptoms
(particularly hostility) were associated with attendance generally, whereas education was
differentially associated with attendance in illness management and recovery. The
attendance indicators developed serve as a useful starting point for further research.
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Fig. 1.
Example attendance patterns. Notes: shaded squares represent sessions attended.
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Fig. 2.
Attendance of illness management and recovery and problem solving groups. Notes: moving
averages include the average of the target session and three previous sessions.
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Table 1
Baseline characteristics and association with indicators of participation.
Mean S.D. Median Mode %
Available
sessions
attended
Time enrolled Periods of attendance Longest
period of
attendance
> 50% Sessions
Indicators of attendance
    % Available sessions
attended
22.5% 27.33% 6.8% 0.0% – 0.88** 0.63* 0.94** 0.88**
    Time enrolled 39.6% 41.69% 18.2% 0% – 0.75** 0.83** 0.71**
    Periods of attendance 0.7 0.82 1.0 0.0 – 0.52* 0.42**
    Longest period of
attendance
9.3 12.45 2.5 0.0 – 0.83**
Baseline characteristics
    Age 47.6 8.85 0.20* 0.26** 0.26** 0.16 0.10
    Hope 17.6 3.94 –0.00 –0.06 –0.06 –0.03 0.01
    IMRS-client 3.4 0.52 0.17 0.12 0.06 0.15 0.18
    IMRS-clinician 3.3 0.55 0.23* 0.26* 0.21* 0.16 0.18
    RAS 124.4 15.69 0.04 0.02 0.05 0.02 0.07
    MARS 3.2 2.34 –0.16 –0.13 –0.13 –0.17 –0.15
    Patient activation 37.7 6.29 –0.07 –0.11 –0.09 –0.10 0.01
    PANSS-total 75.6 15.66
–0.20* –0.10 –0.14 –0.15 –0.18
    PANSS– + 15.8 4.90
–0.19* –0.09 –0.13 –0.14 –0.24**
    PANSS– – 19.1 5.55 –0.12 0.07 –0.01 0.00 0.01
    PANSS-emotional 12.6 4.61 –0.17 –0.11 –0.06 –0.12 –0.17
    PANSS-cognitive 17.2 5.54 –0.05 0.02 –0.05 0.01 –0.01
    PANSS-hostility 8.6 3.19
–0.23* –0.27** –0.26** –0.25** –0.15
    Alcohol use 1.7 0.97 –0.21
–0.24* –0.18 –0.19 –0.20
    Drug use 1.5 0.87 –0.08 –0.12 –0.14 –0.07 –0.05
Notes: IMRS-Client and IMRS-Clinician are the Illness management and recovery scales – Client and Clinician version, RAS = recovery
assessment scale, MARS = medication adherence rating scale; PANSS = positive and negative syndrome scale.
*
p < 0.05
**
p < 0.01
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Table 2
Point-biserial correlations between categorical characteristics and indicators of attendance.
N (%) % Available sessions
attended
Time enrolled Periods of attendance Longest period of
attendance
Female 24 (20.3%) –0.12 –0.14 –0.08 –0.12
White 40 (33.9%) 0.17 0.12 0.10 0.14
Married 16 (13.9%) –0.10 –0.09 –0.11 –0.07
Independent housing 82 (71.3%) 0.16 0.11 0.10 0.12
≥High school/GED 76 (65.5%) 0.18 0.19* 0.27** 0.14
≥ Some college 37 (31.9%) 0.10 0.07 0.28** 0.02
Formal employment 9 (7.8%) 0.06 0.07 0.02 0.06
VA patient 52 (44.1%) 0.00 0.07 0.10 –0.02
Income > $10,000 36 (32.7%) 0.10 0.13 0.24* 0.03
*
p < 0.05
**
p < 0.01
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